دورية أكاديمية

2‐Hydroxyethyl methacrylate (2‐HEMA) sensitization, a global epidemic at its peak in Spain?

التفاصيل البيبلوغرافية
العنوان: 2‐Hydroxyethyl methacrylate (2‐HEMA) sensitization, a global epidemic at its peak in Spain?
المؤلفون: Gatica‐Ortega, Maria Elena, Pastor‐Nieto, Maria Antonia, Giménez‐Arnau, Ana María, Mercader‐García, Pedro, Sanz‐Sánchez, Tatiana, Carrascosa‐Carrillo, José Manuel, Córdoba‐Guijarro, Susana, Sánchez‐Pérez, Javier, Silvestre, Juan Francisco, Frutos, Francisco Javier Ortiz‐de, Tous‐Romero, Fátima, Fernández‐Redondo, Virginia, Serra‐Baldrich, Esther, Ruíz‐González, Inmaculada, González Pérez, Ricardo, Miquel‐Miquel, Javier, Guillén, Paloma Sánchez‐Pedreño, Hervella‐García, Marcos, Heras‐Mendaza, Felipe, Gómez‐de‐la‐Fuente, Enrique
المصدر: Contact Dermatitis (01051873); May2024, Vol. 90 Issue 5, p507-513, 7p
مستخلص: Background: A global epidemic of allergic contact dermatitis to (meth)acrylates has been described in relation to the widespread use of manicure products. Objectives: To evaluate the frequency of sensitization to 2‐hydroxyethyl methacrylate (2‐HEMA) among consecutively patch tested patients with eczema in Spain; the percentage of current relevance; the MOAHLFA index; and, the potential sources of exposure to (meth)acrylates. Methods: From January 2019 to December 2022, 2‐HEMA 2% pet. was prospectively patch tested in 24 REIDAC (Spanish Allergic Contact Dermatitis Registry) centres. Results: Six thousand one hundred thirty‐four patients were consecutively patch tested with 2‐HEMA 2% pet. 265/6134 (4.3%) were positive. Positive reactions of current relevance were identified to involve 184/265 (69%). The efficiency (number of patch tests needed to detect relevant positive patch test reactions) was 34 (6134/184). The variable 'occupational' was found to be significantly associated with a higher risk for relevant positive reactions to 2‐HEMA (OR: 10.9; 95% CI: 8.1–14.9). Conclusion: (Meth)acrylate sensitization is a prevalent health issue in Spain. 2‐HEMA 2% pet. has been identified to be a highly effective (meth)acrylate allergy marker in the GEIDAC baseline series. The responsible authorities should implement policies guaranteeing accurate labelling of industrial, medical, and consumer materials while ensuring the enforcement of said labelling through appropriate legal means. [ABSTRACT FROM AUTHOR]
Copyright of Contact Dermatitis (01051873) is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:01051873
DOI:10.1111/cod.14520